Systematic Literature Reviews at the Heart of Health Technology Assessment: A Comparison Across Markets

• Requirements for SLRs as issued within guidance for HTA submissions in Australia (Pharmaceutical Benefits Advisory Committee [PBAC]), Canada (Canadian Agency for Drugs and Technologies in Health [CADTH]), England and Wales (National Institute for Health and Care Excellence [NICE] Single Technology Appraisal [STA] guidance), France (Haute Autorite de Sante [HAS]), Germany (Gemeinsamer Bundesausschuss [G-BA; Federal Joint Committee]), Ireland (National Centre for Pharmacoeconomics [NCPE]), Scotland (Scottish Medicines Consortium [SMC]), Sweden (The Dental and Pharmaceutical Benefits Agency [TLV]), and Wales (All Wales Medicines Strategy Group [AWMSG]) were examined from the relevant, respective websites in September 2013.